Beneficial effect of rituximab in combination with oral cyclophosphamide in primary chronic cold agglutinin disease

Cold agglutinin disease (CAD) is an uncommon autoimmune hemolytic anemia characterized by B-cell proliferation. Conventional therapies for primary CAD such as corticosteroids, oral alkylating agents, splenectomy, interferon alpha, and plasma exchange are often ineffective at controlling the disease....

Ausführliche Beschreibung